ZanteQ Biosciences L.L.C.
Advancing Drug Development Through Expert DMPK Solutions
About ZanteQ Biosciences
ZanteQ Biosciences L.L.C. is a specialized consulting firm dedicated to drug metabolism and pharmacokinetics (DMPK) for potential new drugs and compounds. Our mission is to accelerate the drug development process by providing comprehensive DMPK expertise that connect between laboratory discovery and clinical trials. We combine scientific rigor with practical insights to help pharmaceutical companies make informed decisions about their drug candidates.
We offer a full spectrum of DMPK services, including experimental design, in vitro drug-metabolizing enzyme incubation studies, dose projection from preclinical data to clinical trial design, and comprehensive pharmacokinetic analysis.
Through strategic partnerships with leading laboratories, we also provide wet-lab services and small animal DMPK studies to support every stage of preclinical drug development.
Our integrated approach ensures that your compounds are thoroughly evaluated for safety, efficacy, and optimal dosing strategies.
Our Services
In Vitro DMPK Studies
Comprehensive in vitro drug-metabolizing enzyme incubation studies and experimental design services to evaluate drug metabolism pathways, enzyme kinetics, metabolic stability, and drug interactions of your compounds.
Preclinical to Clinical Translation
Expert dose projection services that translate in vitro data to clinical trial design, including pharmacokinetic modeling and data analysis to support regulatory submissions.
Clinical Pharmacokinetic Analysis
Our expert analysis transforms complex PK datasets into clear, reliable insights for dose optimization, drug–drug interaction evaluation, and confident development decisions—helping you move promising compounds forward with greater certainty and speed.
Contact Us
